About Elizabeth Flanary
Form D filings for BioMedInnovations in 2024 list Elizabeth Flanary as director.
Elizabeth Flanary first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Elizabeth Flanary in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Elizabeth Flanary works with at each company, as listed on that company's latest Form D.
BioMedInnovations LLC · Form D, Apr 10, 2024
GB
George Barr
Director
RN
Robert Neusner
Chief Operating and Business Officer
CD
Carrie DiMarzio
Executive officer and director
DG
David Gerber
Executive officer